# Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

> **NCT01550471** · PHASE4 · COMPLETED · sponsor: **West Penn Allegheny Health System** · enrollment: 22 (actual)

## Conditions studied

- Asthma
- Allergic Rhinitis

## Interventions

- **DRUG:** Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo
- **DRUG:** Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase
- **DRUG:** QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo
- **DRUG:** QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris
- **DRUG:** Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase
- **DRUG:** Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris

## Key facts

- **NCT ID:** NCT01550471
- **Lead sponsor:** West Penn Allegheny Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550471, "Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01550471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*